한국형 우울장애 약물치료 알고리듬 2006 (Ⅰ)

키워드

참고문헌 (24)

1. Nut DJ, "The role of dopamine and norepinephrine in depression and antidepressant treatment", 67, pp.3~8 (2006)
2. Greenberg P, "Economic implications of treatment-resistant depression among employees", 22, pp.363~373 (2004)
3. APA, "Practice Guideline for the Treatment of Patients With Major Depressive Disorder Second Edition" (2000), Arlington: VA. April
4. Thorpe L, "CANMAT Depres-sion Work Group. Clinical Guide lines for the Treatment of Depre-sive Disorders", 46, pp.5s~90s (2001)
5. Alexopoulos GS, "Expert Consensus Panel for Pharmacotherapy of Depressive Dis-orders in Older Patients. The expert consensus guideline series. Phar-macotherapy of depressive disorders in older patients", (1-86) (2001)
6. Altshuler LL, "Expert Consensus Panel for Depression in Women. The Expert Consensus Guideline Series. Treatment of depression in wo-men", (1-107) (2001)
7. The National Institute for Clinical Excellence (NICE), "Quick refer-ence guide, Depression: management of depression in primary and secondary care" (2004), London
8. Ellis P, "Royal Australian and New Zealand Colege of Psychiatrists Clinical Practice Guidelines Team for Depresion. Australian and New Zealand clinical practice guidelines for the treatment of depre-sion", 38, pp.389~407 (2004)
9. Trivedi MH, "Texas Implementation of Medication Algorithms (TIMA) Guidelines for Treating Major De-pressive Disorder, revised" (2000)
10. Lee MS, "The Executive Commitee For The Korean Medication Algorithm Project For Major Depressive Disorder. The Korean Medication Al-gorithm for Major Depresive Disorder (KMA-MD ) Report of the Korean Society of Depressive and Bipolar Disorders", 10, pp.186~194 (2006)
11. Sachs GS, "The Ex-pert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000", (1-104) (2000)
12. Rojo JE, "Combined antidepressants: clinical experience", (25-31), pp.36~ (2005)
13. Dodd S, "To combine or not to com-bine? A literature review of antidepresant combination therapy", 89, pp.1~1 (2005)
14. Rush AJ, "Acute and longer-term outcomes in depressed out-patients requiring one or several treatment steps: a STAR*D report", 163, pp.1905~1917 (2006)
15. Kocsis JH, "Recurrent depression: patient characteristics, clinical co-urse, and current recommendations for management", 11, pp.6~1 (2006)
16. Hansen RA, "Ef-ficacy and safety of second-generation antidepressants in the treat-ment of major depressive disorder", 143, pp.415~426 (2005)
17. Ruhe HG, "Switching anti-depres-sants after a first selective serotonin reuptake inhibitor in major depres-sive disorder: a systematic review", 67, pp.1836~1855 (2006)
18. Gardner DM, "A comparison of factors used by physicians and patients in the selection of anti-depressant agents", 58, pp.34~40 (2007)
19. Wijkstra J, "Pharmacological treatment for psychotic depression", 19, pp.CD004044~ (2005)
20. Parker G, "Is combination olanzapine and anti-depressant medication asociated with a more rapid response tra-jectory than antidepressant alone?", 162, pp.796~798 (2005)
21. Trivedi MH, "Treatment-resistant depression: new therapies on the horizon", 15, pp.59~70 (2003)
22. Rossini D, "Transcranial magnetic stimulation in treatment-resistant depressed patients: a double- blind, placebo-controlled trial", 137, pp.1~10 (2005)
23. Barbee JG, "The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents intreatment-resistant major depressive disorder", 65, pp.975~981 (2004)
24. Simon JS, "Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder", 66, pp.1216~1220 (2005)

관련 논문AI추천